Perinatal HIV Research Unit, New Nurses Home, Chris Hani Baragwanath Hospital, P.O. Box 114, Diepkloof, Johannesburg 1864, South Africa.
Sex Transm Infect. 2011 Jun;87(4):301-5. doi: 10.1136/sti.2010.047142. Epub 2011 Mar 29.
In the context of a multisite HIV prevention trial in Southern African women, we examined the effectiveness of the Ortho All-Flex Diaphragm, lubricant gel (Replens) and condoms compared to condoms alone on the incidence of herpes simplex virus type 2 (HSV-2) infections.
We analysed data from 2016 sexually active women in Zimbabwe and South Africa. Women were followed quarterly, and specimens obtained at the closing visit from previously HSV-2 seronegative women were retested for HSV-2 antibodies using Focus HerpeSelect Elisa. The first visit at which the participant tested positive for HSV-2 was defined by back-testing. We compared the incidence of HSV-2 after randomisation between study arms in both intent-to-treat (ITT) and per-protocol populations.
210 women acquired HSV-2 during study participation (HSV incidence: 6.8 cases/100 women years). Allocation to the intervention arm was found to offer no benefit in reduction of HSV-2 by modified ITT (HR 1.03, 95% CI 0.78 to 1.35; p=0.85) or per protocol analysis (HR 0.87, 95% CI 0.61 to 1.24; p=0.45).
HSV-2 infection was common in the study population as detected by type-specific Elisa testing. Provision of diaphragm and lubricant gel offered no additional protection against HSV-2 acquisition over male condoms alone.
在南部非洲女性的一项多地点 HIV 预防试验中,我们研究了 Ortho All-Flex 隔膜、润滑剂凝胶(Replens)与 condom 相比 condom 单独使用对单纯疱疹病毒 2 型(HSV-2)感染发生率的影响。
我们分析了来自津巴布韦和南非 2016 名有性行为的活跃女性的数据。每季度对女性进行随访,并对以前 HSV-2 血清阴性的女性在随访结束时采集的标本进行 HSV-2 抗体检测,使用 Focus HerpeSelect Elisa 进行检测。通过回溯检测,将参与者首次出现 HSV-2 阳性的访问定义为首次出现。我们比较了意向治疗(ITT)和方案人群中研究臂之间 HSV-2 随机分组后的发病率。
210 名女性在研究期间感染了 HSV-2(HSV 发病率:6.8 例/100 名女性年)。发现干预组的分配并不能降低 HSV-2 的发病率,无论是在改良的 ITT(HR 1.03,95%CI 0.78 至 1.35;p=0.85)还是方案分析(HR 0.87,95%CI 0.61 至 1.24;p=0.45)中。
在本研究人群中,通过特异性 ELISA 检测发现 HSV-2 感染很常见。与单独使用男用 condom 相比,提供隔膜和润滑剂凝胶并不能提供额外的 HSV-2 感染保护。